Acadian Asset Management LLC Prelude Therapeutics Inc Transaction History
Acadian Asset Management LLC
- $35.4 Billion
- Q1 2025
A detailed history of Acadian Asset Management LLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 529,327 shares of PRLD stock, worth $486,980. This represents 0.0% of its overall portfolio holdings.
Number of Shares
529,327
Previous 485,381
9.05%
Holding current value
$486,980
Previous $617,000
34.36%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PRLD
# of Institutions
56Shares Held
28.3MCall Options Held
23.9KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$10 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$9.31 Million0.09% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$983,4020.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$928,4670.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD976KShares$898,0550.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $33.5M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...